Form 6-K DR REDDYS LABORATORIES For: Jun 14

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

June 2016

Commission File Number 1-15182

 

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                     Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                      No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-            .

 

 

 

---

EXHIBITS

 

Exhibit Number		Description of Exhibits
99.1		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated May 25, 2016.
99.2		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated May 26, 2016.
99.3		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated May 27, 2016.
99.4		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated May 30, 2016.
99.5		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated May 31, 2016.
99.6		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated June 1, 2016.
99.7		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated June 2, 2016.
99.8		Notice to Stock Exchanges of Daily Reporting of Buyback and Extinguishment of Shares, dated June 3, 2016.
99.9		Notice to Stock Exchanges of Extinguishment of Equity Shares bought back by Dr. Reddy’s Laboratories Limited during the period of May 25, 2016 to June 3, 2016, dated June 9, 2016.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

				DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: June 14, 2016				By:		/s/ Sandeep Poddar
						Name:		Sandeep Poddar
						Title:		Company Secretary

Exhibit 99.1

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

May 25, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on May 25, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (25/05/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		7,670		63,278		70,948		BSE- 3,040.90 NSE- 3,043.23
Cumulative Equity Shares bought as on Yesterday (upto 24/05/2016) (B)								11,57,318
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 25/05/2016 (A) +(B) – (E)								12,28,266

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 3,74,27,60,272.68 (Rupees three hundred and seventy four crores twenty seven lakhs sixty thousand two hundred and seventy two and sixty eight paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 25/05/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.2

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

May 26, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on May 26, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (26/05/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		12,461		16,178		28,639		BSE- 3,075.60 NSE- 3,076.73
Cumulative Equity Shares bought as on Yesterday (upto 25/05/2016) (B)								12,28,266
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 26/05/2016 (A) +(B) – (E)								12,56,905

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 3,83,08,60,758.10 (Rupees three hundred and eighty three crores eight lakhs sixty thousand seven hundred and fifty eight and ten paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 26/05/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.3

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

May 27, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on May 27, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (27/05/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		-		6,078		6,078		3,099.94
Cumulative Equity Shares bought as on Yesterday (upto 26/05/2016) (B)								12,56,905
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 27/05/2016 (A) +(B) – (E)								12,62,983

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 3,84,97,02,190.38 (Rupees three hundred and eighty four crores ninety seven lakhs two thousand one hundred and ninety and thirty eight paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 27/05/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.4

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

May 30, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on May 30, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (30/05/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		55,000		75,325		130,325		BSE: 3,159,56 NSE: 3,163.70
Cumulative Equity Shares bought as on Yesterday (upto 27/05/2016) (B)								12,62,983
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 30/05/2016 (A) +(B) – (E)								13,93,308

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 42,617,83,397.68 (Rupees four hundred and twenty six crores seventeen lakhs eighty three thousand three hundred and ninety seven and sixty eight paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 30/05/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.5

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

May 31, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on May 31, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (31/05/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		54,000		129,248		183,248		BSE: 3,184.72 NSE: 3,178.76
Cumulative Equity Shares bought as on Yesterday (upto 30/05/2016) (B)								13,93,308
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 31/05/2016 (A) +(B) – (E)								15,76,556

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 4,84,46,06,012.42 (Rupees four hundred and eighty four crores forty six lakhs six thousand and twelve and forty two paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 31/05/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.6

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

June 1, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on June 1, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (1/06/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		40,000		36,131		76,131		BSE: 3,194.02 NSE: 3,179.73
Cumulative Equity Shares bought as on Yesterday (upto 31/05/2016) (B)								15,76,556
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 1/06/2016 (A) +(B) – (E)								16,52,687

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 5,08,72,53,838.47 (Rupees five hundred and eight crores seventy two lakhs fifty three thousand and eight hundred and thirty eight and forty seven paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 1/06/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.7

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

June 2, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on June 2, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (2/06/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		10,002*		60,189		70,191		BSE: 3,175.05 NSE: 3,175.33
Cumulative Equity Shares bought as on Yesterday (upto 01/06/2016) (B)								16,52,687
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 02/06/2016 (A) +(B) – (E)								17,22,878

 

*	Includes 2 physical shares

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 5,31,01,30,619.34 (Rupees five hundred and thirty one crores one lakhs thirty thousand and six hundred and nineteen and thirty four paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 02/06/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.8

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

June 3, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Buyback of equity shares of Rs. 5/- each (“Share”) of Dr. Reddy’s Laboratories Limited (“Company”) at a maximum price of Rs. 3,500/- per share for a maximum amount of Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) via the open market through stock exchanges (“Buyback”)

With reference to the captioned subject matter, the Company hereby submits the daily report pursuant to Regulation 15(i) of the SEBI (Buy Back of Securities) Regulations, 1998 regarding equity shares bought back on June 3, 2016:

 

Name of the Broker		Number of Equity Shares Bought Back on (3/06/2016)				Total shares bought back		Average Price of Acquisition (Rs.)
		BSE		NSE
Kotak Securities Limited (A)		35,000		151,656		1,86,656		BSE: 3,158.17 NSE: 3,159.59
Cumulative Equity Shares bought as on Yesterday (upto 02/06/2016) (B)								17,22,878
Less : Quantity Closed Out Today (C)								Nil
Quantity Closed Out as on Yesterday (D)								Nil
Total Quantity closed out (E=C+D)								Nil
Total Equity Shares bought back as on 03/06/2016 (A) +(B) – (E)								19,09,534

Please note that the total amount earmarked for Buyback by the Company is Rs. 15,69,41,71,500 (Rupees One Thousand Five Hundred Sixty Nine Crores Forty One Lacs Seventy One Thousand Five Hundred only) (excluding brokerage, transaction charges and taxes, if any), out of which the Company has utilized Rs. 5,89,98,37,670.03 (Rupees five hundred and eighty nine crores ninety eight lakhs thirty seven thousand and six hundred and seventy and three paisa only) on cumulative basis for Buyback (excluding brokerage, transaction charges and taxes, if any) till date 03/06/2016. The indicative maximum number of equity shares to bought back would be 44,84,049 at the proposed Maximum Buyback price and at Maximum Buyback size.

 

For Dr. Reddy’s Laboratories Limited

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

CC: New York Stock Exchange Inc. (Stock Code: RDY)

Exhibit 99.9

 

				Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507
				Tel:      +9140 4900 2900 Fax:     +9140 4900 2999
				Email:  [email protected] www.drreddys.com

June 9, 2016

 

BSE Limited Department of Corporate Services                      Listing Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 500124		The National Stock Exchange of India Limited Listing Department Exchange Plaza Plot no. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Code: DRREDDY

Dear Sir/Madam,

 

Sub:				Extinguishment of 752,214 equity shares bought back by Dr. Reddy’s Laboratories Limited (‘Company’)

With reference to the Company’s ongoing buyback process, we would like to inform you that the Company has extinguished 752,214 equity shares on June 8, 2016. Please find enclosed herewith the debit confirmation received from NSDL in this regard (letter no. II/CA/COM/18876/2016 dated June 8, 2016).

These shares were bought back in electronic form by the Company during the period – May 25, 2016 to June 3, 2016 (both days inclusive).

This is for your information and records.

With regards,

/s/Sandeep Poddar

Sandeep Poddar Company Secretary

Encl: as above

CC: New York Stock Exchange Inc. (Stock Code: RDY)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Lowered to INR5,700 at Goldman Sachs
• Aristocrat Leisure Completes Acquisition of Neo Group Ltd. (f/k/a NeoGames) for $29.50 per Share
• Kidoz Inc. Announces 2023 Total Revenue of $13,326,824